Back to my company list

Divergene

The AI engine Fit Assessment

Beta

Divergene leverages machine learning to enhance genomic data analysis and supports the expansion of therapeutics in gene therapy.

Blurb

Developer of AI-driven analytics and informatics for the cell and gene therapy and bioprocessing industries. Divergene's services integrate multimodal data, break down data silos, and create advanced machine learning models to offer actionable insights. Their platform provides a secure and accessible environment for the standardization, computation, and analysis of multimodal data, helping organizations to retain ownership of their samples and data. Divergene collaborates with CROs, CDMOs, and cell and gene therapy companies to enhance their next-generation sequencing capabilities.

HQ Location

United States

Founded

Not available

Employees

1 - 10

Total funding raised

Not available

Funding Status

Not available
Subspaces
  • Genomic Data Analysis

Divergene design and develop NGS bioinformatics that accelerates gene therapy and editing. We provide custom NGS bioinformatics pipelines and analyses through a simple and flexible SaaS model. We are Ph.D. bioinformaticians to serve the computational genomics needs of biotechnology companies and academics within the gene therapy and gene editing spaces. We frequently help with biomarker discovery, genetic target diligence, building analytical pipelines, analyzing and integrating both public and client-generated NGS datasets, and data visualization.



Many NGS projects can be stalled for months, or even years, due to a dearth of bioinformatics expertise. Even worse, poorly executed analyses can result in incorrect conclusions and an immense subsequent misallocation of resources. Sometimes it doesn’t make business sense to build a team of in-house bioinformaticians or they are already overloaded with projects. Outsource your NGS bioinformatic needs to Divergene.